The phage display technology is a valuable approach in the biomedical field that offers a rapid, efficient and inexpensive tool for detecting protein-protein interactions, investigating receptor binding sites, identifying epitopes, mimotopes as well as functional sites of antigens. Due to its high flexibility, this technique has become an attractive target for scientists and methods based on phage display are allowed to explore the mechanisms of diseases, improve diagnostic capability and design potential agents for therapeutics.
Phage display is a completely random manner. In Creative Biolabs, we are able to construct large repertoires of antibodies (109-1012), which are displayed on the surface of filamentous phages, and from which peptides or proteins with desired properties can be screened for the development of drugs, vaccines, and reagents. Finally they are decoded by sequencing of phage DNA.
Fig.1 Schematic presentation of antibody fragments. (Bazan, 2012)
Creative Biolabs has constructed both large non-immune and synthetic libraries as well as smaller immune libraries based on capturing a single immune repertoire. Our phage display platforms represent advanced methodology for high-throughput screening for therapeutic antibody candidates of interest. Initially, phage display library is incubated with targets immobilized on solid scaffolds. Specific library phages bind to target molecules, while the unbound phages are washed away. Then specific phages are eluted and amplified by infecting E. coli cells. After several rounds of selection, amplified clones can be sequenced and analyzed to obtain diagnostic and therapeutic agents with wanted properties.
Fig.3 Phage display selection. (Frei, 2016)
Except for traditional biopannings, we are also pleased to introduce many other specific selection strategies.
Phage display is a robust technology for selection of high-quality human antibodies from different libraries. In addition to being able to recognize antibodies in a fast, high-throughput mode, this tool is currently being used to identify fully human therapeutic antibodies according to market-approved regulatory procedures.
If you’re interested in our phage display services or other multifunctional platforms, please contact us for more details.
For Research Use Only | Not For Clinical Use